Related Experiment Video
Updated: Jan 2, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Meropenem pharmacokinetics during relapsing peritonitis due to ESBL-producing Enterobacteriaciae in a liver
Kensuke Shoji1, Jumpei Saito2, Yusuke Oho2
1Division of Infectious Diseases Department of Medical Subspecialties National Center for Child Health and Development Tokyo Japan.
Abstract:
We report on an 8-year-old girl with Wilson disease who developed three episodes of peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli after liver transplantation. Massive ascites were thought to account for low meropenem concentrations with standard dosing. Extending the infusion achieved higher troughs, greater time above minimum inhibitory concentration.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Elimination by Renal Route: Tubular Secretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Kidney Transplant II: Surgical Procedure
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

